CD19-CART Treatment for ALL

NCT03232619 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
4
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Bioray Laboratories

Collaborators